Send password reminder...
Subscribe to New Research on MDL 19660
Also Known As:
5-(4-chlorophenyl)-2,4-dihydro-2,4-dimethyl-3H-1,2,4-triazole-3-thione; MDL 19,660; MDL-19660
relevant articles (
Bio-Agent Context: Research Results
Heterocyclic Compounds: 60
1-Ring Heterocyclic Compounds
MDL 19660: 1
01/01/1990 - "
The results of the present investigation indicate that MDL 19,660 may produce in the dog a reversible thrombocytopenia in the form of vacuolar degeneration and subsequent destruction of the platelet by means other than aggregation or steroid-responsive mechanisms.
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
We wish to acknowledge and thank the US National Library of Medicine and Medline staff for providing access to their data.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.